首页> 外国专利> Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid

Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid

机译:用于鼻腔给药的药物组合物,其包含皮质类固醇和喹诺酮或夫西地酸

摘要

The invention relates to a pharmaceutical composition of unit dose for inhalation by a human subject comprising a topical corticoid and a quinolone or fucidic acid, characterized in that the ratio of the weight of the topical corticoid to the weight of the quinolone or fucidic acid is between 0.02 and 20 and the amount of quinolone or of fucidic acid is less than 1 mg. This composition can be administered by nasal spray and is used for treating the upper and lower respiratory tract, in particular sinusitis and nasal polyps.
机译:本发明涉及用于人受试者吸入的单位剂量的药物组合物,其包含局部皮质类固醇和喹诺酮或夫西地酸,其特征在于局部皮质类固醇的重量与喹诺酮或夫西地酸的重量之比为0.02和20,喹诺酮或岩藻酸的含量小于1毫克。该组合物可以通过鼻喷雾剂施用,并且用于治疗上下呼吸道,特别是鼻窦炎和鼻息肉。

著录项

  • 公开/公告号US9636350B2

    专利类型

  • 公开/公告日2017-05-02

    原文格式PDF

  • 申请/专利权人 MATTHEW KRAYENBUHL;

    申请/专利号US201214006414

  • 发明设计人 MATTHEW KRAYENBUHL;

    申请日2012-03-19

  • 分类号A61K31/58;A61K9;A61K9/12;A61K45/06;A61K31/47;A61K31/56;A61K31/575;A61K31/496;A61K31/573;

  • 国家 US

  • 入库时间 2022-08-21 13:43:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号